loadpatents
Patent applications and USPTO patent grants for CHAMBERLAIN; Jeffrey S..The latest application filed is for "use of ribonucleotide reductase alone or in combination with micro-dystrophin to treat duchenne muscular dystrophy striated muscle disease".
Patent | Date |
---|---|
Use Of Ribonucleotide Reductase Alone Or In Combination With Micro-dystrophin To Treat Duchenne Muscular Dystrophy Striated Muscle Disease App 20200405824 - ODOM; Guy L. ;   et al. | 2020-12-31 |
Novel Micro-dystrophins And Related Methods Of Use App 20200095298 - Chamberlain; Jeffrey S. ;   et al. | 2020-03-26 |
Novel Micro-dystrophins And Related Methods Of Use App 20200031890 - Chamberlain; Jeffrey S. ;   et al. | 2020-01-30 |
Micro-dystrophins and related methods of use Grant 10,479,821 - Chamberlain , et al. Nov | 2019-11-19 |
Production Of Viral Vectors App 20190127758 - Chamberlain; Jeffrey S. ;   et al. | 2019-05-02 |
Production of viral vectors Grant 10,167,485 - Chamberlain , et al. J | 2019-01-01 |
Novel Micro-dystrophins And Related Methods Of Use App 20180148488 - Chamberlain; Jeffrey S. ;   et al. | 2018-05-31 |
Cell and gene based methods to improve cardiac function Grant 9,868,937 - Regnier , et al. January 16, 2 | 2018-01-16 |
Muscle-specific Crispr/cas9 Editing Of Genes App 20170362635 - Chamberlain; Jeffrey S. ;   et al. | 2017-12-21 |
Production Of Viral Vectors App 20170204431 - CHAMBERLAIN; Jeffrey S. ;   et al. | 2017-07-20 |
Production of viral vectors Grant 9,453,240 - Chamberlain , et al. September 27, 2 | 2016-09-27 |
Cell And Gene Based Methods To Improve Cardiac Function App 20160186139 - Regnier; Michael ;   et al. | 2016-06-30 |
Production Of Viral Vectors App 20140193858 - CHAMBERLAIN; Jeffrey S. ;   et al. | 2014-07-10 |
Production of viral vectors Grant 8,637,313 - Chamberlain , et al. January 28, 2 | 2014-01-28 |
Nucleic acid sequences encoding peptides with utrophin spectrin-like repeats Grant 8,501,920 - Chamberlain , et al. August 6, 2 | 2013-08-06 |
Mutant Muscle-specific Enhancers App 20110097761 - Chamberlain; Jeffrey S. ;   et al. | 2011-04-28 |
Production Of Viral Vectors App 20110033926 - Chamberlain; Jeffrey S. ;   et al. | 2011-02-10 |
Production of viral vectors Grant 7,820,441 - Chamberlain , et al. October 26, 2 | 2010-10-26 |
Compositions and methods for systemic nucleic acid sequence delivery Grant 7,655,467 - Chamberlain , et al. February 2, 2 | 2010-02-02 |
Nucleic acid sequences encoding peptides with utrophin spectrin-like repeats App 20080167260 - Chamberlain; Jeffrey S. ;   et al. | 2008-07-10 |
Compositions and methods for systemic nucleic acid sequence delivery App 20050158281 - Chamberlain, Jeffrey S. ;   et al. | 2005-07-21 |
Mini-dystrophin nucleic acid sequences Grant 6,869,777 - Chamberlain , et al. March 22, 2 | 2005-03-22 |
Methods of treatment with mini-dystrophin nucleic acid sequences App 20050049219 - Chamberlain, Jeffrey S. ;   et al. | 2005-03-03 |
Production of viral vectors App 20040087029 - Chamberlain, Jeffrey S. ;   et al. | 2004-05-06 |
Mini -dystrophin nucleic acid and peptide sequences App 20030216332 - Chamberlain, Jeffrey S ;   et al. | 2003-11-20 |
Helper adenovirus vectors Grant 6,451,596 - Chamberlain , et al. September 17, 2 | 2002-09-17 |
Adenovirus vectors Grant 6,083,750 - Chamberlain , et al. July 4, 2 | 2000-07-04 |
Adenovirus vectors Grant 6,063,622 - Chamberlain , et al. May 16, 2 | 2000-05-16 |
Adenovirus vectors Grant 6,057,158 - Chamberlain , et al. May 2, 2 | 2000-05-02 |
Adenovirus vectors Grant 5,994,132 - Chamberlain , et al. November 30, 1 | 1999-11-30 |
Multiplex genomic DNA amplification for deletion detection Grant 5,582,989 - Caskey , et al. December 10, 1 | 1996-12-10 |
NCAGE Code | 48M79 | CHAMBERLAIN, JEFFREY S |
CAGE Code | 48M79 | CHAMBERLAIN, JEFFREY S |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.